Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre De Clercq

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Steroid Biochemistry and Molecular Biology|July 26, 2005
Altered Vitamin D receptor-coactivator interactions reflect superagonism of Vitamin D analogsGuy Eelen, Lieve Verlinden, Mark Van Camp, et al.
Archives of Dermatological Research|March 26, 2004
Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVBPetra De Haes, Marjan Garmyn, Annemieke Verstuyf, et al.
Plos One|October 4, 2014
1,25-Dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type 1 diabetes patientsTom L Van Belle, An-Sofie Vanherwegen, Dorien Feyaerts, et al.
Journal of Photochemistry and Photobiology. B, Biology|January 25, 2005
1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damagePetra De Haes, Marjan Garmyn, Annemieke Verstuyf, et al.
Chemistry & Biology|October 23, 2008
Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptorGuy Eelen, Noelia Valle, Yoshiteru Sato, et al.
Molecular Pharmacology|February 25, 2005
Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interactionGuy Eelen, Lieve Verlinden, Natacha Rochel, et al.
Anticancer Research|August 12, 2009
Microarray analysis of MCF-7 breast cancer cells treated with 1,25-dihydroxyvitamin D3 or a 17-methyl-D-ring analogEls Vanoirbeek, Guy Eelen, Lieve Verlinden, et al.
Archives of Biochemistry and Biophysics|January 2, 2007
Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantlyG Satyanarayana Reddy, Matthew Robinson, Guochun Wang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Steroid Biochemistry and Molecular Biology|July 26, 2005
Altered Vitamin D receptor-coactivator interactions reflect superagonism of Vitamin D analogsGuy Eelen, Lieve Verlinden, Mark Van Camp, et al.
Archives of Dermatological Research|March 26, 2004
Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVBPetra De Haes, Marjan Garmyn, Annemieke Verstuyf, et al.
Plos One|October 4, 2014
1,25-Dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type 1 diabetes patientsTom L Van Belle, An-Sofie Vanherwegen, Dorien Feyaerts, et al.
Journal of Photochemistry and Photobiology. B, Biology|January 25, 2005
1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damagePetra De Haes, Marjan Garmyn, Annemieke Verstuyf, et al.
Chemistry & Biology|October 23, 2008
Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptorGuy Eelen, Noelia Valle, Yoshiteru Sato, et al.
Molecular Pharmacology|February 25, 2005
Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interactionGuy Eelen, Lieve Verlinden, Natacha Rochel, et al.
Anticancer Research|August 12, 2009
Microarray analysis of MCF-7 breast cancer cells treated with 1,25-dihydroxyvitamin D3 or a 17-methyl-D-ring analogEls Vanoirbeek, Guy Eelen, Lieve Verlinden, et al.
Archives of Biochemistry and Biophysics|January 2, 2007
Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantlyG Satyanarayana Reddy, Matthew Robinson, Guochun Wang, et al.
Pageof 2